ProMIS Neurosciences, Inc.
PMN
$0.52
$0.0193.79%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 68.68% | 57.69% | |||
| Gross Profit | -68.68% | -57.69% | |||
| SG&A Expenses | -197.40% | 71.97% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -43.57% | 63.42% | |||
| Operating Income | 43.57% | -63.42% | |||
| Income Before Tax | -102.57% | 453.54% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -102.57% | 453.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -102.57% | 453.54% | |||
| EBIT | 43.57% | -63.42% | |||
| EBITDA | 43.62% | -63.54% | |||
| EPS Basic | -102.20% | 332.86% | |||
| Normalized Basic EPS | -69.70% | 332.93% | |||
| EPS Diluted | -102.20% | 332.86% | |||
| Normalized Diluted EPS | -69.66% | 332.57% | |||
| Average Basic Shares Outstanding | 15.97% | 51.86% | |||
| Average Diluted Shares Outstanding | 15.80% | 52.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||